Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

175.65 +0.39 (+0.22%)
Official Closing Price Updated: 4:10 PM EST, Jan 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,201,448
Open 176.01
Bid (Size) 174.00 (3)
Ask (Size) 176.24 (6)
Prev. Close 175.26
Today's Range 173.98 - 176.12
52wk Range 153.58 - 207.32
Shares Outstanding N/A
Dividend Yield 3.53%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AbbVie Vs. Novartis: Which Has The Technical Edge Before Q4 Earnings?
AbbVie and Novartis to report Q4 earnings. AbbVie in stagnating trend, Novartis bullish. Breakdown of technical charts. Novartis has advantage, investors watch for post-earnings movement. 
Via Benzinga
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people. 
Via Benzinga
Topics Government
Exposures Political

Performance

YTD
-2.11%
-2.11%
1 Month
-0.31%
-0.31%
3 Month
-12.83%
-12.83%
6 Month
-5.22%
-5.22%
1 Year
+6.51%
+6.51%

More News

Read More
A Glimpse Into The Expert Outlook On AbbVie Through 15 Analysts
Via Benzinga
I Own 4 High-Yield Dividend Stocks. Here's Why I Own Each One.
Via The Motley Fool
Why AbbVie Stock Popped While the Market Flopped on Monday
Via The Motley Fool
$1000 Invested In AbbVie 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Unpacking the Latest Options Trading Trends in AbbVie
Via Benzinga
AbbVie Builds Momentum With Immunology Growth, Goldman Remains Positive
Via Benzinga
Biotech And Healthcare Stocks Poised For Gains Ahead
Via Talk Markets
Topics ETFs Stocks / Equities
Is AbbVie Stock a Buy?
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever
Via The Motley Fool
Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why
Via Investor's Business Daily
Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever
Via The Motley Fool
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever
Via The Motley Fool
Healthcare And Biotech Stocks Lag The Market Again
Via Talk Markets
Topics Stocks / Equities
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Via Benzinga
Topics Government
Exposures Political
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
Via Benzinga
Topics Economy
Exposures Interest Rates
Top Research Reports For Visa, AbbVie & Analog Devices
Via Talk Markets
Topics Stocks / Equities
10 One Decision Stocks To Buy Now
Via Talk Markets
Topics Stocks / Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
2 Brilliant Dividend Growth Stocks That Can Supercharge Your Portfolio
Via The Motley Fool
3 High-Yielding Dividend Stocks That Could Be Ideal Investments for Retirees
Via The Motley Fool
Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal
Via Benzinga
3 High-Yield Dividend Stocks to Buy in 2025
Via The Motley Fool
3 Incredible Dividend Stocks to Buy in 2025
Via The Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.